Preparing Providers and Payers for Interoperability Mandates
Healthcare providers and payers must prepare for new interoperability mandates set to take effect in January 2027, as outlined in the CMS final rule.
Introduction
As the healthcare landscape evolves, providers and payers are gearing up for significant changes mandated by the Centers for Medicare and Medicaid Services (CMS). The upcoming interoperability and prior authorization final rule, effective January 2027, will reshape how these entities manage data exchange and prior authorizations.
Overview of the Final Rule
Scott Rossignol, a consultant at FHIR Solutions and eHealth Exchange, will address these critical changes during the Interoperability & HIE Preconference Forum at the HIMSS26 Global Health Conference & Exhibition in Las Vegas. He emphasizes that most providers and payers are currently unprepared for the mandates outlined in the final rule, which was released in January 2024.
The final rule aims to enhance the efficiency of prior authorizations and data exchange processes. Key affected payers include Medicare Advantage, Medicaid, the Children's Health Insurance Program (CHIP), and Affordable Care Act exchange plans. These organizations are required to implement essential application programming interfaces (APIs) such as the Prior Authorization API, Provider Access API, and an expanded Patient Access API.
Key Requirements for Implementation
Rossignol notes that payers must develop an API that allows providers to submit and receive electronic decisions directly within their Electronic Health Records (EHR) or practice management systems. Starting in 2026, the requirements will include expedited prior authorization decisions, but the challenges will escalate with the 2027 mandates.
The session at HIMSS26 will focus on how providers will transmit data to payers and how payers will respond to this data. Rossignol clarifies that the discussion will not delve into the technical specifics of the rule but will instead highlight pilot projects he and others have conducted within the HL7 Da Vinci Project.
The HL7 Da Vinci Project
The HL7 Da Vinci Project is a private-sector initiative designed to accelerate the adoption of HL7 FHIR (Fast Healthcare Interoperability Resources) standards, thereby improving data exchange between payers and providers. Rossignol explains, "We create pilots to stand up the technologies. You can be successful and save money."
Event Details
During the session titled "CMS 0057 and ePrior Authorization: What Providers and Payers Need to Know," Rossignol will be joined by notable speakers including Srihari Muthyala, Director of Health Care Solutions and Interoperability at Cambia Health Solutions; Anna Taylor, Assistant Vice President of Population Health & Value-Based Care at MultiCare Health System; and Michael Westover, Vice President of Population Health Informatics at Providence. This session is scheduled for Monday, March 9, at 10:35 a.m. at HIMSS26 in Las Vegas.
Conclusion
As the healthcare industry prepares for these interoperability mandates, understanding the implications of the CMS final rule is crucial for both providers and payers. Engaging in discussions and pilot projects will be essential for successful implementation.
Source: Preparing providers and payers for interoperability mandates - HealthcareITNews
Source:
Related News
Oman Pilots Digital Health Cards at Hajj, Presents to WHO
Oman showcased its successful Digital Hajj Health Card pilot at a WHO meeting in Geneva, demonstrating how over 500,000 pilgrims used secure digital health records during the 2024-2025 Hajj seasons. The initiative represents one of the world's largest tests of portable digital health records during mass population movement.
India Upgrades JANANI Maternal Health Platform
India's Ministry of Health and Family Welfare has upgraded its JANANI maternal and child health platform to improve digital health monitoring and continuity of care. The enhanced platform now features QR-based health cards, automated alerts, and integration with national health systems.
Abu Dhabi Biobank Partners with Japan for Stem Cell Therapy
Abu Dhabi Biobank has formed a strategic partnership with Human Life CORD Japan to develop and manufacture umbilical cord-derived stem cell therapies locally. The collaboration aims to create the UAE's first localized manufacturing pathway for regenerative treatments.
Ready to Transform Your Clinic?
Join hundreds of healthcare providers who trust daoini for their practice management
